- Compound
- CJC-1295 without DAC (tetrasubstituted GRF(1-29)) with Ipamorelin
- CJC-1295 form
- Without DAC — no albumin-binding maleimidopropionyl lysine at the C terminus
- CJC-1295 backbone
- GRF(1-29) amide, substituted at positions 2, 8, 15 and 27
- GRF(1-29) reference
- PubChem CID 16129620 · CAS 86168-78-7
- Ipamorelin sequence
- Aib-His-D-2-Nal-D-Phe-Lys-NH2 (5 residues)
- Ipamorelin identity reference
- CAS 170851-70-4 · PubChem CID 9831659
- Vial content
- 20 mg total — 10 mg CJC-1295 (no DAC), 10 mg Ipamorelin
- Purity, lot 2157-TSN/TSBN112-A
- 99.92% by RP-HPLC against a 98.0% specification
- Certificate sample
- 5 mg / 5 mg CJC-1295 / Ipamorelin from the same lot
- Identity method
- Not reported on the current certificate
- Storage
- −20 °C, sealed, protected from light
- Availability
- CJC-1295 / Ipamorelin for sale online in a 20 mg vial. Ships within the United States.
- Intended use
- Laboratory research only. Not for human or veterinary use.